Vimarsana
Biggest News Aggregation in the World

Invokana Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invokana Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invokana Tablets Today - Breaking & Trending Today

Lupin shares trade 3% higher on tentative USFDA approvals - Vimarsana News

Lupin shares trade 3% higher on tentative USFDA approvals

Published: November 24, 2023

On November 23, Lupin announced receiving the USFDA's tentative approval for its Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets to market a generic equivalent of Invokana Tablets of Janssen Pharmaceuticals, Inc at its Pithampur facility.

Source: moneycontrol.com
Related Topics:
United StatesDrug AdministrationBausch Lomb Inc Prolensa Ophthalmic SolutionInvokana Tablets Of Janssen Pharmaceuticals IncUnited States FoodAbbreviated New Drug ApplicationCanagliflozin TabletsInvokana TabletsJanssen PharmaceuticalsBromfenac Ophthalmic SolutionLomb IncProlensa Ophthalmic SolutionLupin SharesLupin StockSfda ApprovalsBbreviated New Drug Application Anda Upin Drugs
Lupin receives tentative approval from US FDA for diabetes medication - Vimarsana News

Lupin receives tentative approval from US FDA for diabetes medication

Published: November 23, 2023

This product will be manufactured at Lupin’s Pithampur facility in India

Source: moneycontrol.com
Related Topics:
United StatesDrug AdministrationJanssen Pharmaceuticals IncCanagliflozin TabletsLupin LimitedUnited States FoodAbbreviated New Drug ApplicationInvokana TabletsJanssen PharmaceuticalsDiabetes MedicationProduct Launch